West D C, Kumar S
Christie Hospital and Holt Radium Institute, Clinical Research Laboratories, Manchester, England, United Kingdom.
Exp Cell Res. 1989 Jul;183(1):179-96. doi: 10.1016/0014-4827(89)90428-x.
Hyaluronidase treatment of hyaluronic acid produced a series of oligosaccharides. Those between 3 and 16 disaccharides in length stimulated angiogenesis in vivo and the proliferation of tissue cultured endothelial cells in vitro. This effect appears to be cell type specific, as no stimulation of fibroblasts or smooth muscle cells was observed. Endothelial cells were found to endocytose both high- and low-molecular-mass hyaluronate, which might be receptor mediated. Fibroblasts and smooth muscle cells, cultured under the same conditions, showed negligible uptake of hyaluronate. Thus, the cell-specific effects may be due to the differences in internalization of hyaluronate. High-molecular-weight hyaluronate both inhibited endothelial cell proliferation and disrupted newly formed monolayers. These data are consistent with the ability of hyaluronate to inhibit new blood vessel formation in vivo and also suggest that hyaluronate metabolism plays a pivotal role in the regulation of angiogenesis.
用透明质酸酶处理透明质酸产生了一系列寡糖。长度在3至16个二糖之间的那些寡糖在体内刺激血管生成,并在体外刺激组织培养的内皮细胞增殖。这种效应似乎具有细胞类型特异性,因为未观察到对成纤维细胞或平滑肌细胞的刺激。发现内皮细胞会内吞高分子量和低分子量的透明质酸盐,这可能是受体介导的。在相同条件下培养的成纤维细胞和平滑肌细胞对透明质酸盐的摄取可忽略不计。因此,细胞特异性效应可能是由于透明质酸盐内化的差异所致。高分子量透明质酸盐既抑制内皮细胞增殖,又破坏新形成的单层细胞。这些数据与透明质酸盐在体内抑制新血管形成的能力一致,也表明透明质酸盐代谢在血管生成的调节中起关键作用。